Evidence map›Paper›PMID 23114623›Full record

ArticleNeuroreport2012

Resveratrol attenuates L-DOPA-induced hydrogen peroxide toxicity in neuronal cells.

Carina S Peritore, Angela Ho, Bryan K Yamamoto, Scott E Schaus

Open access · greenAbstract readComparative Study
In one paragraph

Article in Neuroreport, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Optimization of Flavonoid Extraction inInternational journal of analytical chemistry · 2019
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Carina S PeritoreDepartment of aChemistry bBiology, Boston University, Boston, Massachusetts 02215, USA.
Angela Ho
Bryan K Yamamoto
Scott E Schaus
Boston University · USUniversity of Toledo · US

Funding

METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATER01DA007606 · NIDA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI YAMAMOTO, BRYAN K · 1992 to 2016
$5.1M
The Design and Implementation of Asymmetric Organocatalysis in SynthesisR01GM078240 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI SCHAUS, SCOTT EDWARD · 2007 to 2018
$2.9M
NIDA NIH HHS R01 DA007606NIGMS NIH HHS R01 GM078240
6 · The paper itself

Abstract

A variety of polyphenol antioxidant compounds derived from natural products have demonstrated neuroprotective activity against neuronal cell death. The objective of this study was to investigate the effect of resveratrol (RESV) and bioflavonoids in attenuating hydrogen peroxide (H(2)O(2))-induced oxidative stress in neuronal cells. H2O2 levels were increased by the addition of L-3,4-dihydroxyphenylalanine (L-DOPA) to cultured dopaminergic SKNSH cells. H(2)O(2) was monitored by peroxyfluor-1, a selective H(2)O(2) optical probe. To examine the neuroprotective effects of RESV and bioflavonoids against L-DOPA, we cotreated RESV, quercetin, or (-) epigallocatechin gallate with L-DOPA and monitored for H(2)O(2) levels. The combination of RESV and L-DOPA was 50% more effective at reducing H(2)O(2) levels than the combination of quercetin or epigallocatechin gallate with L-DOPA. However, the combination of each antioxidant with L-DOPA was effective at preserving cell viability.

Indexed as

AntioxidantsCatechinCell Line, TumorCell SurvivalDrug Evaluation, PreclinicalDrug InteractionsFibroblastsFluoresceinsHumansHydrogen PeroxideLevodopaMonoamine OxidaseNerve Tissue ProteinsNeuroblastomaNeuronsNeuroprotective AgentsAntioxidantsCatechinepigallocatechin gallateFluoresceinsHydrogen PeroxideLevodopaMonoamine OxidaseNerve Tissue ProteinsNeuroprotective Agentsperoxyfluor-1QuercetinResveratrolStilbenesTyrosineTyrosine 3-Monooxygenase

Identifiers

PMID23114623
PMCPMC5705237
OpenAlexW2102864544

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.